Roche Articles
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
Kosan opens Ph II study of alvespimycin
28 January 2008
Roche finally succeeds in Ventana bid
28 January 2008
FDA clears APP's Polmyxin B Sulfate
21 January 2008
Roche extends tender offer for Ventana
21 January 2008
Rebecca Taub joins VIA Pharmaceuticals as SVP of R&D
21 January 2008
Roche appoints Steven Sembler as VP of commercial operations
21 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
India patent battle over Tarceva opens new CL front
21 January 2008
NICE changes earlier MabThera appraisal
21 January 2008
FDA warns: severe pain with bisphosphonates
14 January 2008
Actelion becomes full member of Swiss Interpharma
14 January 2008
Myfortic cuts GI effects in transplant recipients
14 January 2008
Barr's generic Kytril gains final FDA approval
7 January 2008
Stock Commentary - Europe - week to January 7, 2008
7 January 2008
UK row over ban on NHS patients buying drugs
7 January 2008
Roche initiates Ph II of Genmab's R1507
7 January 2008
HERmark assay identifies best Herceptin responders
24 December 2007
Avastin shows good safety profile in Ph II breast cancer trial
24 December 2007
Neoadjuvant Xeloda reduces breast tumor size in Ph II trial
24 December 2007
Teva's generic CellCept gets CHMP OK
24 December 2007
Roche's MabThera gets nod for EU label extension
24 December 2007
Xeloda and Avastin to get expanded indications
24 December 2007
OSI's Tarceva to debut in Japan Dec 18
24 December 2007
Fourth Genmab/Roche Ab enters clinic in USA
17 December 2007
Gottlieb Keller names as Roche's General Counsel
17 December 2007
Roche's MabThera yields strong data in CLL
17 December 2007
Stock Commentary - Europe - week to Dec 10, 2007
17 December 2007
Trimeris reveals strategic plan
17 December 2007
Roche and ARK to collaborate on HIV drug monitoring prod
17 December 2007
Stock Commentary - Europe - week to Dec 3, 2007
10 December 2007
ODAC
10 December 2007
Driven by Avastin, ovarian cancer market set to reach $1.6B by 2016
10 December 2007
Stock Commentary - New York week to Nov 26, 2007
3 December 2007
Stock Commentary - Europe - week to Nov 26, 2007
3 December 2007
US FDA panel calls for label revisions on Tamiflu and Relenza
3 December 2007
US FDA to review drugs' effects on children
3 December 2007
Most UK NHS patients not told of drug options
26 November 2007
Roche files Actemra with FDA for RA
26 November 2007
Headlines 25 years ago this week....
26 November 2007
CHMP OKs Roche's Avastin for RCC
26 November 2007
FDA OKs Mircera but ruling delays launch
26 November 2007
Roche drug combo helps Pegintron-resistant patients
21 November 2007
Strong HCV clearance data for R1626 regimen
21 November 2007
German drug discounts facing legal hurdles
19 November 2007
Headlines 25 years ago this week....
19 November 2007
Roche starts due diligence on Ventana
19 November 2007
New biologicals are the stars of the 2007 ACR meeting
19 November 2007
Valeant slumps into 3rd-qtr $12M loss
12 November 2007
Genmab's 9-month 2007 revenues triple
12 November 2007
Isabelle Raizon-Ounis made VP of drug development at Amira
12 November 2007
Stock Commentary - Europe - week to Nov 5, 2007
12 November 2007
Stock Commentary - New York week to Nov 5, 2007
12 November 2007
Breast cancer market set to reach $2.9B in 2013, but still no cure
12 November 2007
HGS' Albuferon sees strong Ph IIb data
12 November 2007
Tarceva helps OSI reach $30M 3rd-qtr profit
12 November 2007
Roche extends tender offer for Ventana
5 November 2007
Roche's Invirase non-inferior to Kaletra
5 November 2007
Roche updates CellCept warning label
5 November 2007
Roche's R1507 effective at Ph I against solid tumors
5 November 2007
Kosan gets epothilone rights back from Roche
5 November 2007
Supplemental indication for Chugai's Sigmart
5 November 2007
Stock Commentary - Europe - week to October 22, 2007
29 October 2007
UPDATE: 2007 NASSO conference hears encouraging data on GSK's alli, Orexigen's Contrave et al
29 October 2007
UPDATE: Thailand negotiations on drug prices continue
29 October 2007
Amgen wins in Roche Mircera patent suit
29 October 2007
EC reinstates Roche's Viracept
29 October 2007
Under 5% of patients discontinue GSK's alli due to AEs
29 October 2007
Tarceva cleared for new indication in Japan
29 October 2007
Thailand negotiations on drug prices continue
29 October 2007
Galenica offers $915M for Canada
22 October 2007
Headlines 25 years ago this week....
22 October 2007
AHF attacks another US firm for HIV drug price
22 October 2007
Daclizumab impresses as MS therapy
22 October 2007
Genentech's 3rd-qtr income climbs 21% with sales of $2.9B; but analysts question reliance on Avastin
22 October 2007
Aspreva/Roche
15 October 2007
Stock Commentary - New York week to Oct 8, 2007
15 October 2007
Biojector withdrawn from US FDA review
15 October 2007
UK stem cell research group launched
8 October 2007
Indonesia to begin copycat Tamiflu production
8 October 2007
EMEA OKs smaller capsule Tamiflu
8 October 2007
Chugai withdraws Epogin application
8 October 2007
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
